- Project CP22 (2022 — 2027)
- Cancer Research Programme
Mexico
Background
Despite being highly preventable, stark cervical cancer (CC) disparities exist globally. CC is the second leading cause of cancer mortality among Mexican women, where CC detection, diagnosis, and treatment delays result from suboptimal implementation of and adherence to longstanding Mexican early detection, diagnosis, and treatment guidelines, which have been in existence since 1974.
Aims
We propose to identify barriers to and facilitators of adherence to the Mexican guidelines for follow-up from an abnormal screen onward down the CC care cascade (MGMACS, Mexican Guidelines for Managing Abnormal Cervical Cancer Screening Tests), and to develop strategies to increase adherence to these guidelines in clinics in Tlalpan, a Southern district of Mexico City.
Project plan
Following an Implementation Mapping approach, guided by the Consolidated Framework for Implementation Research (CFIR), the Health Belief Model, and the Implementation Outcomes Framework (IOF), we will evaluate the determinants of implementation and outcomes of the current MGMACS implementation and develop a logic model describing the process for improving adherence to the MGMACS from abnormal screens onwards down the cascade, among patients, providers, and clinics (Aim 1). Next, we will select and adapt implementation strategies that address the barriers identified to improve adherence to MGMACS (Aim 2). In both aims, we will use qualitative and quantitative methods for data collection and synthesis of findings, embedding them together in a multistage integrated convergent mixed methods design and analysis approach. We aim to gather data to inform a future external application for a large-scale implementation study on improving adherence to MGMACS.
This project will provide a model for an implementation science-based approach to improving CC early detection, diagnosis, and treatment programs in similar under-resourced contexts in Latin America and beyond, contributing to the reduction and ultimate elimination of CC.
Principal investigators
-
Donna L Spiegelman Yale University, United States
Funding organisations
Would this content be useful for a friend or colleague?